EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase II)

Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection

Maureen M Jonas, Rene Romero, Philip Rosenthal, Chuan-Hao Lin, Gabriella Verucchi, Jessica Wen, William F Balistreri, Suzanne Whitworth, Sanjay Bansal, Daniel H Leung, Michael R Narkewicz, Regino P Gonzalez-Peralta und 11 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2024-06 · 78 (6) · 1342-1354

DOI: 10.1002/jpn3.12045 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 21.04.2024. Verfasst von Maureen M Jonas und 22 weiteren Autor:innen. Beteiligte Einrichtung: Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Sofosbuvir, Heterocyclic Compounds, 4 or More Rings, Carbamates, Antiviral Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Gilead Sciences Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The safety and efficacy of sofosbuvir–velpatasvir in children aged 3–17 years with chronic hepatitis C virus (HCV) infection of any genotype were evaluated.

Methods

In this Phase 2, multicenter, open‐label study, patients received once daily for 12 weeks either sofosbuvir–velpatasvir 400/100 mg tablet (12–17 years), 200/50 mg low dose tablet or oral granules (3–11 years and ≥17 kg), or 150/37.5 mg oral granules (3–5 years and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SofosbuvirHeterocyclic Compounds, 4 or More RingsCarbamatesAntiviral AgentsHepatitis C, ChronicDrug CombinationsHumansChildMaleChild, PreschoolFemaleAdolescentTreatment OutcomeHepacivirusSustained Virologic ResponseGenotypeBenzimidazolesBenzopyrans

Stichwörter der Autor:innen

direct‐acting antiviralpediatricspharmacokineticspolymerase inhibitor

Substanzen

SofosbuvirHeterocyclic Compounds, 4 or More RingsCarbamatesAntiviral Agentssofosbuvir-velpatasvir drug combinationDrug CombinationsvelpatasvirBenzimidazolesBenzopyrans

Autor:innen und Institutionen

  • Boston Children's Hospital, Boston, Massachusetts, USA.
  • Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA.
  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California San Francisco, Benioff Children's Hospital, San Francisco, California, USA.
  • Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Università di Bologna, Bologna, Italy.
  • University of Pennsylvania and The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Förderung

  • Gilead Sciences Inc.

Zitieren

APA

Jonas, M. M., Romero, R., Rosenthal, P., Lin, C. H., Verucchi, G., Wen, J., Balistreri, W. F., Whitworth, S., Bansal, S., Leung, D. H., Narkewicz, M. R., Gonzalez-Peralta, R. P., Mangia, A., Karnsakul, W., Rao, G. S., Shao, J., de Jong, J., Parhy, B., Osinusi, A., …, & Schwarz, K. B. (2024). Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection. Journal of Pediatric Gastroenterology and Nutrition, 78(6), 1342-1354. https://doi.org/10.1002/jpn3.12045

Vancouver

Jonas MM, Romero R, Rosenthal P, Lin CH, Verucchi G, Wen J, et al. Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection. Journal of Pediatric Gastroenterology and Nutrition. 2024;78(6):1342-1354. doi:10.1002/jpn3.12045

BibTeX
@article{Jonas2024,
  author = {Jonas, Maureen M and Romero, Rene and Rosenthal, Philip and Lin, Chuan-Hao and Verucchi, Gabriella and Wen, Jessica and Balistreri, William F and Whitworth, Suzanne and Bansal, Sanjay and Leung, Daniel H and Narkewicz, Michael R and Gonzalez-Peralta, Regino P and Mangia, Alessandra and Karnsakul, Wikrom and Rao, Girish S and Shao, Jiang and de Jong, Jan and Parhy, Bandita and Osinusi, Anu and Kersey, Kathryn and Murray, Karen F and Sokal, Etienne M and Schwarz, Kathleen B},
  title = {Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  volume = {78},
  number = {6},
  pages = {1342--1354},
  doi = {10.1002/jpn3.12045}
}
Kostenlos starten →